Breaking News

Vertex Expands Cell and Gene Therapy Footprint

New 344,000 square foot cell and genetic therapies research and manufacturing facility to be built in the Boston Seaport.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

At a dedication of the new Jeffrey Leiden Center for Cell and Genetic Therapies in Boston’s Seaport, Vertex Pharmaceuticals unveiled plans to build another 344,000 square foot facility in the Seaport to support the company’s growth of its cell and genetic therapies programs. With the completion of this new site expected in 2025, Vertex will occupy 1.9 million square feet of real estate in the Seaport across five sites, making it the largest biotech in Boston in terms of square footage. Jeffr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters